Immuno-Biological Laboratories Co Ltd
TSE:4570
Income Statement
Earnings Waterfall
Immuno-Biological Laboratories Co Ltd
Revenue
|
788.1m
JPY
|
Cost of Revenue
|
-299m
JPY
|
Gross Profit
|
489.1m
JPY
|
Operating Expenses
|
-438.9m
JPY
|
Operating Income
|
50.2m
JPY
|
Other Expenses
|
-243m
JPY
|
Net Income
|
-192.7m
JPY
|
Income Statement
Immuno-Biological Laboratories Co Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
674
N/A
|
670
-1%
|
682
+2%
|
711
+4%
|
666
-6%
|
729
+9%
|
735
+1%
|
715
-3%
|
781
+9%
|
718
-8%
|
734
+2%
|
797
+9%
|
745
-7%
|
742
0%
|
734
-1%
|
725
-1%
|
735
+1%
|
758
+3%
|
797
+5%
|
809
+2%
|
832
+3%
|
781
-6%
|
723
-7%
|
628
-13%
|
592
-6%
|
577
-3%
|
580
+1%
|
594
+2%
|
601
+1%
|
603
+0%
|
611
+1%
|
609
0%
|
636
+5%
|
648
+2%
|
679
+5%
|
687
+1%
|
754
+10%
|
795
+5%
|
815
+3%
|
867
+6%
|
788
-9%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(290)
|
(298)
|
(306)
|
(325)
|
(321)
|
(362)
|
(322)
|
(312)
|
(325)
|
(266)
|
(300)
|
(311)
|
(313)
|
(327)
|
(328)
|
(309)
|
(302)
|
(281)
|
(293)
|
(315)
|
(307)
|
(321)
|
(309)
|
(279)
|
(290)
|
(359)
|
(356)
|
(361)
|
(349)
|
(256)
|
(257)
|
(263)
|
(267)
|
(271)
|
(271)
|
(262)
|
(261)
|
(268)
|
(282)
|
(298)
|
(299)
|
|
Gross Profit |
384
N/A
|
372
-3%
|
376
+1%
|
386
+3%
|
345
-11%
|
367
+6%
|
413
+13%
|
403
-2%
|
457
+13%
|
452
-1%
|
434
-4%
|
486
+12%
|
431
-11%
|
415
-4%
|
406
-2%
|
416
+2%
|
433
+4%
|
477
+10%
|
504
+6%
|
494
-2%
|
525
+6%
|
460
-12%
|
413
-10%
|
348
-16%
|
302
-13%
|
217
-28%
|
224
+3%
|
233
+4%
|
252
+8%
|
347
+38%
|
355
+2%
|
346
-2%
|
370
+7%
|
377
+2%
|
407
+8%
|
425
+4%
|
493
+16%
|
527
+7%
|
533
+1%
|
569
+7%
|
489
-14%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(473)
|
(480)
|
(494)
|
(484)
|
(532)
|
(555)
|
(573)
|
(587)
|
(551)
|
(527)
|
(535)
|
(566)
|
(606)
|
(1 719)
|
(1 572)
|
(1 515)
|
(1 473)
|
(526)
|
(529)
|
(541)
|
(574)
|
(634)
|
(655)
|
(694)
|
(709)
|
(813)
|
(817)
|
(796)
|
(779)
|
(588)
|
(568)
|
(546)
|
(517)
|
(499)
|
(471)
|
(465)
|
(460)
|
(468)
|
(459)
|
(441)
|
(439)
|
|
Selling, General & Administrative |
(473)
|
(290)
|
(493)
|
(484)
|
(526)
|
(348)
|
(566)
|
(580)
|
(551)
|
(313)
|
(517)
|
(549)
|
(589)
|
(310)
|
(1 572)
|
(1 515)
|
(1 473)
|
(353)
|
(529)
|
(541)
|
(574)
|
(397)
|
(656)
|
(694)
|
(709)
|
(494)
|
(817)
|
(796)
|
(779)
|
(321)
|
(568)
|
(546)
|
(517)
|
(310)
|
(471)
|
(465)
|
(460)
|
(289)
|
(459)
|
(441)
|
(439)
|
|
Research & Development |
0
|
(153)
|
0
|
0
|
0
|
(159)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1 240)
|
0
|
0
|
0
|
(173)
|
0
|
0
|
0
|
(237)
|
0
|
0
|
0
|
(318)
|
0
|
0
|
0
|
(267)
|
0
|
0
|
0
|
(189)
|
0
|
0
|
0
|
(180)
|
0
|
0
|
0
|
|
Depreciation & Amortization |
0
|
(38)
|
0
|
0
|
(7)
|
0
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(170)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(48)
|
(7)
|
(6)
|
0
|
(193)
|
(17)
|
(17)
|
(17)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Operating Income |
(89)
N/A
|
(108)
-21%
|
(118)
-9%
|
(99)
+16%
|
(187)
-90%
|
(188)
-1%
|
(159)
+15%
|
(183)
-15%
|
(95)
+48%
|
(75)
+21%
|
(101)
-34%
|
(80)
+21%
|
(175)
-118%
|
(1 305)
-647%
|
(1 166)
+11%
|
(1 100)
+6%
|
(1 040)
+5%
|
(49)
+95%
|
(25)
+49%
|
(47)
-88%
|
(48)
-3%
|
(174)
-261%
|
(242)
-39%
|
(346)
-43%
|
(407)
-18%
|
(595)
-46%
|
(592)
+0%
|
(563)
+5%
|
(527)
+6%
|
(241)
+54%
|
(213)
+12%
|
(200)
+6%
|
(147)
+27%
|
(122)
+17%
|
(63)
+48%
|
(40)
+36%
|
33
N/A
|
58
+75%
|
74
+26%
|
128
+73%
|
50
-61%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(7)
|
(6)
|
(7)
|
12
|
16
|
11
|
82
|
73
|
64
|
62
|
(16)
|
(17)
|
(7)
|
(4)
|
4
|
6
|
(3)
|
(3)
|
(1)
|
2
|
0
|
4
|
(21)
|
(44)
|
(65)
|
(96)
|
(102)
|
(108)
|
(110)
|
(87)
|
(91)
|
(90)
|
(111)
|
(150)
|
(161)
|
(174)
|
(140)
|
(199)
|
(150)
|
(110)
|
(102)
|
|
Non-Reccuring Items |
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(771)
|
(919)
|
(919)
|
(921)
|
(3)
|
(11)
|
(11)
|
(8)
|
(8)
|
4
|
4
|
4
|
4
|
(0)
|
(0)
|
(0)
|
(0)
|
(7)
|
(7)
|
(5)
|
(7)
|
(2)
|
(2)
|
(4)
|
(192)
|
(191)
|
(191)
|
(191)
|
|
Gain/Loss on Disposition of Assets |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
46
|
0
|
0
|
0
|
|
Total Other Income |
(3)
|
2
|
10
|
28
|
37
|
16
|
8
|
(4)
|
(10)
|
1
|
(1)
|
(5)
|
(14)
|
(10)
|
(8)
|
(6)
|
5
|
3
|
2
|
1
|
(2)
|
14
|
15
|
15
|
29
|
13
|
32
|
33
|
8
|
17
|
20
|
19
|
15
|
29
|
27
|
29
|
28
|
6
|
55
|
54
|
56
|
|
Pre-Tax Income |
(99)
N/A
|
(112)
-13%
|
(115)
-2%
|
(59)
+49%
|
(134)
-129%
|
(161)
-20%
|
(69)
+57%
|
(114)
-64%
|
(41)
+64%
|
(30)
+27%
|
(118)
-301%
|
(101)
+14%
|
(195)
-93%
|
(2 089)
-969%
|
(2 089)
+0%
|
(2 019)
+3%
|
(1 959)
+3%
|
(52)
+97%
|
(35)
+32%
|
(55)
-56%
|
(58)
-5%
|
(164)
-184%
|
(244)
-49%
|
(371)
-52%
|
(423)
-14%
|
(659)
-56%
|
(663)
-1%
|
(639)
+4%
|
(629)
+2%
|
(311)
+51%
|
(292)
+6%
|
(278)
+5%
|
(248)
+11%
|
(250)
-1%
|
(198)
+21%
|
(187)
+6%
|
(82)
+56%
|
(281)
-241%
|
(211)
+25%
|
(119)
+44%
|
(186)
-56%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(5)
|
(11)
|
(5)
|
(7)
|
(2)
|
4
|
(2)
|
0
|
(6)
|
(5)
|
(5)
|
(5)
|
(1)
|
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
(5)
|
(6)
|
(9)
|
(10)
|
(6)
|
(6)
|
(8)
|
(9)
|
(10)
|
(10)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(8)
|
(8)
|
(7)
|
|
Income from Continuing Operations |
(106)
|
(118)
|
(121)
|
(65)
|
(141)
|
(166)
|
(80)
|
(119)
|
(48)
|
(32)
|
(115)
|
(104)
|
(195)
|
(2 094)
|
(2 094)
|
(2 024)
|
(1 964)
|
(53)
|
(36)
|
(58)
|
(60)
|
(167)
|
(247)
|
(376)
|
(429)
|
(668)
|
(673)
|
(644)
|
(635)
|
(319)
|
(300)
|
(288)
|
(259)
|
(259)
|
(207)
|
(196)
|
(92)
|
(290)
|
(220)
|
(127)
|
(193)
|
|
Income to Minority Interest |
0
|
3
|
5
|
8
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(106)
N/A
|
(115)
-9%
|
(116)
-1%
|
(57)
+51%
|
(131)
-129%
|
(158)
-21%
|
(75)
+53%
|
(116)
-55%
|
(47)
+59%
|
(32)
+32%
|
(115)
-260%
|
(104)
+10%
|
(195)
-89%
|
(2 094)
-972%
|
(2 094)
+0%
|
(2 024)
+3%
|
(1 964)
+3%
|
(53)
+97%
|
(36)
+32%
|
(58)
-60%
|
(60)
-5%
|
(167)
-178%
|
(247)
-48%
|
(376)
-52%
|
(429)
-14%
|
(668)
-56%
|
(673)
-1%
|
(644)
+4%
|
(635)
+1%
|
(319)
+50%
|
(300)
+6%
|
(288)
+4%
|
(259)
+10%
|
(259)
0%
|
(207)
+20%
|
(196)
+5%
|
(92)
+53%
|
(290)
-216%
|
(220)
+24%
|
(127)
+42%
|
(193)
-52%
|
|
EPS (Diluted) |
-16.23
N/A
|
-17.92
-10%
|
-17.81
+1%
|
-8.78
+51%
|
-20.13
-129%
|
-24.21
-20%
|
-11.52
+52%
|
-17.89
-55%
|
-7.26
+59%
|
-4.86
+33%
|
-15.95
-228%
|
-14.17
+11%
|
-26.76
-89%
|
-287.53
-974%
|
-282.94
+2%
|
-273.5
+3%
|
-265.37
+3%
|
-7.01
+97%
|
-4.27
+39%
|
-6.84
-60%
|
-7.15
-5%
|
-19.83
-177%
|
-28.33
-43%
|
-43.14
-52%
|
-49.13
-14%
|
-76.01
-55%
|
-72.21
+5%
|
-69.16
+4%
|
-68.13
+1%
|
-34.23
+50%
|
-32.26
+6%
|
-30.88
+4%
|
-27.76
+10%
|
-27.78
0%
|
-22.22
+20%
|
-21
+5%
|
-9.84
+53%
|
-31.11
-216%
|
-23.58
+24%
|
-13.6
+42%
|
-20.69
-52%
|